![Achieve Life Sciences, Inc. logo](/logos/ACHV.webp)
Achieve Life Sciences, Inc.
NASDAQ:ACHV
Overview | Financials
Company Name | Achieve Life Sciences, Inc. |
Symbol | ACHV |
Currency | USD |
Price | 4.165 |
Market Cap | 143,031,515 |
Dividend Yield | 0% |
52-week-range | 3.03 - 5.98 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. John A. Bencich M.B.A. |
Website | https://www.achievelifesciences.com |
An error occurred while fetching data.
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD